Literature DB >> 21904509

Diagnosis and treatment of pouchitis.

Bo Shen1, Bret A Lashner.   

Abstract

Ileal pouch-anal anastomosis following total proctocolectomy has become part of the standard surgical treatment for patients with ulcerative colitis or familial adenomatous polyposis who require colectomy. Although this surgery has improved patient quality of life and significantly reduced the risk of dysplasia or neoplasia in ulcerative colitis patients, complications are common. Pouchitis is the most common long-term complication of ileal pouch surgery and has a significant adverse impact on patient quality of life. The diagnosis and differential diagnosis of pouchitis are not straightforward, and the management of pouchitis, particularly chronic antibiotic-refractory pouchitis, which is one of the leading causes of pouch failures, can be challenging.

Entities:  

Keywords:  Ileal pouch; inflammatory bowel disease; restorative proctocolectomy

Year:  2008        PMID: 21904509      PMCID: PMC3093723     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN: 1554-7914


  83 in total

1.  Possible role of human cytomegalovirus in pouchitis after proctocolectomy with ileal pouch-anal anastomosis in patients with ulcerative colitis.

Authors:  Damian Casadesus; Tatsuo Tani; Toshifumi Wakai; Satoshi Maruyama; Tsuneo Iiai; Haruhiko Okamoto; Katsuyoshi Hatakeyama
Journal:  World J Gastroenterol       Date:  2007-02-21       Impact factor: 5.742

2.  Increased cytokine transcripts in pouchitis reflect the degree of inflammation but not the underlying entity.

Authors:  C Schmidt; T Giese; B Ludwig; M Menges; M Schilling; S C Meuer; S Zeuzem; A Stallmach
Journal:  Int J Colorectal Dis       Date:  2005-08-23       Impact factor: 2.571

3.  Expression of cytokines, inducible nitric oxide synthase, and matrix metalloproteinases in pouchitis: effects of probiotic treatment.

Authors:  S Ulisse; P Gionchetti; S D'Alò; F P Russo; I Pesce; G Ricci; F Rizzello; U Helwig; M G Cifone; M Campieri; C De Simone
Journal:  Am J Gastroenterol       Date:  2001-09       Impact factor: 10.864

4.  Differentiating risk factors for acute and chronic pouchitis.

Authors:  Jean-Paul Achkar; Mohammad Al-Haddad; Bret Lashner; Feza H Remzi; Aaron Brzezinski; Bo Shen; Farah Khandwala; Victor Fazio
Journal:  Clin Gastroenterol Hepatol       Date:  2005-01       Impact factor: 11.382

5.  Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial.

Authors:  Paolo Gionchetti; Fernando Rizzello; Ulf Helwig; Alessandro Venturi; Karen Manon Lammers; Patrizia Brigidi; Beatrice Vitali; Gilberto Poggioli; Mario Miglioli; Massimo Campieri
Journal:  Gastroenterology       Date:  2003-05       Impact factor: 22.682

6.  Factors associated with disease activity of pouchitis after surgery for ulcerative colitis.

Authors:  J Kuisma; H Järvinen; A Kahri; M Färkkilä
Journal:  Scand J Gastroenterol       Date:  2004-06       Impact factor: 2.423

7.  Pouchitis following pelvic pouch operation for ulcerative colitis. Incidence, cumulative risk, and risk factors.

Authors:  D Ståhlberg; K Gullberg; L Liljeqvist; G Hellers; R Löfberg
Journal:  Dis Colon Rectum       Date:  1996-09       Impact factor: 4.585

8.  Ileal pouch-anal anastomoses complications and function in 1005 patients.

Authors:  V W Fazio; Y Ziv; J M Church; J R Oakley; I C Lavery; J W Milsom; T K Schroeder
Journal:  Ann Surg       Date:  1995-08       Impact factor: 12.969

9.  Sulfate-reducing bacteria colonize pouches formed for ulcerative colitis but not for familial adenomatous polyposis.

Authors:  M Duffy; L O'Mahony; J C Coffey; J K Collins; F Shanahan; H P Redmond; W O Kirwan
Journal:  Dis Colon Rectum       Date:  2002-03       Impact factor: 4.585

10.  An enema formulation of alicaforsen, an antisense inhibitor of intercellular adhesion molecule-1, in the treatment of chronic, unremitting pouchitis.

Authors:  P Miner; M Wedel; B Bane; J Bradley
Journal:  Aliment Pharmacol Ther       Date:  2004-02-01       Impact factor: 8.171

View more
  11 in total

1.  Refractory pouchitis improves after administration of the green tea polyphenol EGCG: a retrospective review.

Authors:  Minesh Mehta; Shifat Ahmed; Gerald Dryden
Journal:  Int J Colorectal Dis       Date:  2017-09-20       Impact factor: 2.571

Review 2.  Review article: the pathogenesis of pouchitis.

Authors:  K M Schieffer; E D Williams; G S Yochum; W A Koltun
Journal:  Aliment Pharmacol Ther       Date:  2016-08-24       Impact factor: 8.171

3.  Dysbiosis-Induced Secondary Bile Acid Deficiency Promotes Intestinal Inflammation.

Authors:  Sidhartha R Sinha; Yeneneh Haileselassie; Linh P Nguyen; Carolina Tropini; Min Wang; Laren S Becker; Davis Sim; Karolin Jarr; Estelle T Spear; Gulshan Singh; Hong Namkoong; Kyle Bittinger; Michael A Fischbach; Justin L Sonnenburg; Aida Habtezion
Journal:  Cell Host Microbe       Date:  2020-02-25       Impact factor: 21.023

4.  Efficacy of granulocyte and monocyte apheresis for antibiotic-refractory pouchitis after proctocolectomy for ulcerative colitis: an open-label, prospective, multicentre study.

Authors:  Takayuki Yamamoto; Toshiaki Tanaka; Tadashi Yokoyama; Takahiro Shimoyama; Hiroki Ikeuchi; Motoi Uchino; Toshiaki Watanabe
Journal:  Therap Adv Gastroenterol       Date:  2016-11-25       Impact factor: 4.409

5.  The Probiotic Compound VSL#3 Modulates Mucosal, Peripheral, and Systemic Immunity Following Murine Broad-Spectrum Antibiotic Treatment.

Authors:  Ira Ekmekciu; Eliane von Klitzing; Ulrike Fiebiger; Christian Neumann; Petra Bacher; Alexander Scheffold; Stefan Bereswill; Markus M Heimesaat
Journal:  Front Cell Infect Microbiol       Date:  2017-05-05       Impact factor: 5.293

Review 6.  Alicaforsen: An Emerging Therapeutic Agent for Ulcerative Colitis and Refractory Pouchitis.

Authors:  Terron Anthony Hosten; Ke Zhao; Hong Qiu Han; Gang Liu; Xiang Hui He
Journal:  Gastroenterology Res       Date:  2014-05-02

Review 7.  Revisiting Inflammatory Bowel Disease: Pathology, Treatments, Challenges and Emerging Therapeutics Including Drug Leads from Natural Products.

Authors:  Karma Yeshi; Roland Ruscher; Luke Hunter; Norelle L Daly; Alex Loukas; Phurpa Wangchuk
Journal:  J Clin Med       Date:  2020-04-28       Impact factor: 4.241

8.  Disease-Specific Enteric Microbiome Dysbiosis in Inflammatory Bowel Disease.

Authors:  Hengameh Chloé Mirsepasi-Lauridsen; Katleen Vrankx; Jørgen Engberg; Alice Friis-Møller; Jørn Brynskov; Inge Nordgaard-Lassen; Andreas Munk Petersen; Karen Angeliki Krogfelt
Journal:  Front Med (Lausanne)       Date:  2018-11-20

9.  NOD2 Genetic Variants Predispose One of Two Familial Adenomatous Polyposis Siblings to Pouchitis Through Microbiome Dysbiosis.

Authors:  Kathleen M Schieffer; Justin R Wright; Leonard R Harris; Sue Deiling; Zhaohai Yang; Regina Lamendella; Gregory S Yochum; Walter A Koltun
Journal:  J Crohns Colitis       Date:  2017-10-27       Impact factor: 9.071

Review 10.  Management of ulcerative colitis in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease.

Authors:  Shu-Chen Wei; Ting-An Chang; Te-Hsin Chao; Jinn-Shiun Chen; Jen-Wei Chou; Yenn-Hwei Chou; Chiao-Hsiung Chuang; Wen-Hung Hsu; Tien-Yu Huang; Tzu-Chi Hsu; Chun-Chi Lin; Hung-Hsin Lin; Jen-Kou Lin; Wei-Chen Lin; Yen-Hsuan Ni; Ming-Jium Shieh; I-Lun Shih; Chia-Tung Shun; Yuk-Ming Tsang; Cheng-Yi Wang; Horng-Yuan Wang; Meng-Tzu Weng; Deng-Chyang Wu; Wen-Chieh Wu; Hsu-Heng Yen; Jau-Min Wong
Journal:  Intest Res       Date:  2017-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.